Article Information
History
- August 17, 2022.
Article Versions
- Version 1 (October 11, 2021 - 05:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jurre den Haan, MD, PhD1,
- Frederique J. Hart de Ruyter, MD1,
- Benjamin Lochocki, PhD2,
- Maurice A.G.M. Kroon, PharmD3,
- E. Marleen Kemper, PharmD, PhD3,
- Charlotte E. Teunissen, PhD4,
- Bart van Berckel, MD, PhD5,
- Philip Scheltens, MD, PhD1,
- Jeroen J. Hoozemans, PhD6,
- Aleid van de Kreeke, MD, PhD7,
- Frank D. Verbraak, MD, PhD8,
- Johannes F. de Boer, PhD2,* and
- Femke H. Bouwman, MD, PhD1,**
- 1Amsterdam UMC, location VUmc, Alzheimer Center, Neurology, Amsterdam, The Netherlands
- 2VU Amsterdam, Department of Physics, LaserLaB, The Netherlands
- 3Amsterdam UMC, location AMC, Department of Pharmacy and Clinical Pharmacology, Amsterdam, The Netherlands
- 4Amsterdam UMC, location VUmc, Neurochemistry lab, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands
- 5Amsterdam UMC, location VUmc, Department of Nuclear Medicine, Amsterdam, The Netherlands
- 6Amsterdam UMC, location VUmc, Department of Pathology, Amsterdam Neuroscience, The Netherlands
- 7Amsterdam UMC, location AMC, Ophthalmology Department Amsterdam, The Netherlands
- 8Amsterdam UMC, location VUmc, Ophthalmology Department, Amsterdam, The Netherlands
- ↵**Corresponding author: Femke Bouwman, MD, PhD, Alzheimer center Amsterdam, Department of Neurology, Amsterdam UMC, Mailbox 7057, 1007 MB Amsterdam, The Netherlands, Phone: +31204440685, Fax: +31204448529, Email: femke.bouwman{at}amsterdamumc.nl
↵* Equal contribution.
Posted August 17, 2022.
No difference in retinal fluorescence after oral curcumin intake in amyloid proven AD cases compared to controls
